Bottom line
SHISX vs JDOC: the short answer
SHISX (Blackrock Health Sciences Opportunities Portfolio) and JDOC (JPMorgan Healthcare Leaders ETF) are both mutual funds.
But SHISX is far broader, holding 155 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
JDOC is cheaper at 0.65% vs 1.16% — a difference of $51 a year per $10,000 invested.
Over one year, SHISX returned +15.9% vs +14.9% for JDOC.
Updated Nov 19, 2026
SHISX vs JDOC side by side
| SHISX | JDOC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | BlackRock | J.P. Morgan |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.16% | 0.65% |
| Annual cost per $10k | $116 | $65 |
| 10-yr cost on $10k (prospectus) | $1,409 | $810 |
| Max front load | — | None |
| 12b-1 fee | 0.25% | — |
| 1-yr return | +15.9% | +14.9% |
| 5-yr return (annualized) | +5.5% | — |
| 10-yr return (annualized) | +9.5% | — |
| Best quarter | +17.5% | +11.3% |
| Worst quarter | −11.5% | −11.9% |
| Net assets (fund) | $5.9B | $9.1M |
| Number of holdings | 155 | 61 |
| Portfolio turnover | 49% | 92% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SHISX | JDOC | Difference |
|---|---|---|---|
| 2025 | +15.9% | +14.9% | +1.0% |
| 2024 | +3.8% | −0.6% | +4.4% |
Source: Fund prospectus bar charts
Holdings overlap
14 of SHISX's top 25 holdings also appear in JDOC's top 25.
| Holding | SHISX | JDOC |
|---|---|---|
| Eli Lilly & Company | 12.29% | 7.76% |
| Johnson & Johnson | 8.77% | 4.82% |
| Unitedhealth Group Inc | 6.10% | 5.85% |
| Merck & Company Inc | 4.94% | 4.82% |
| Abbvie Inc | 3.94% | 7.85% |
| Thermo Fisher Scientific Inc | 3.02% | 3.73% |
| Edwards Lifesciences Corp | 2.51% | 1.73% |
| Danaher Corp | 2.00% | 2.16% |
| Abbott Laboratories | 1.97% | 3.11% |
| Intuitive Surgical Inc | 1.95% | 1.93% |
| Biogen Inc | 1.21% | 1.56% |
| Astrazeneca Plc | 1.21% | 3.76% |
| Stryker Corp | 1.15% | 2.23% |
| Regeneron Pharmaceuticals Inc | 0.91% | 1.60% |
Source: SEC Form N-PORT
SHISX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
FAQ
What is the difference between SHISX and JDOC?
Which is cheaper, SHISX or JDOC?
Should I own both SHISX and JDOC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.